The Global Nasal Sprays Market is slated to witness accelerated growth with increasing regulatory approvals for newer products. According to a report by Fortune Business Insights, titled “Nasal Spray Market Size, Share and Global Trend By Type (Salt Water Solutions, Decongestants, Steroid, Antihistamine), By Application (Asthma, Cold, Nasal Allergies), By Patient Type Infant, Paediatric, Adults), By End User (Hospitals, Clinics, Ambulatory Surgery Centres, Home Care Settings) Geography Forecast till 2026,” the market is likely to surge in the coming years with encouragement from increasing FDA approval of newer products.
Browse Complete Report Details at:
Some of the major companies that are present in the Global Nasal Spray Market are
- ADAPT Pharma
- Egalet Corporation
- ARIUS FORMULATIONS PVT LTD.
- J Pharmaceuticals
- AURENA Laboratories AB
- INNOVUS PHARMACEUTICALS, INC.
- Sandoz International GmbH
- Leeford Healthcare Limited
- Sunovion Pharmaceuticals
- Nephron Pharmaceuticals
- Mylan N.V
FDA Approves Janssen’s nasal spray ‘Spravato’
In March 2019, the US Food and Drug Administration (USFDA) passed a usage approval for “Spravato”. Janssen’s Spravato was a fast processing antidepressant drug. The approval has encouraged Janssen’s counterparts and many have been encouraged to introduce newer products. Spravato was a product with high efficacy and much reduced side effects. The approval for Spravato will have a positive impact on the global market and is likely to favor the growth of the market in the coming years.
Increasing Incidence of Allergic Rhinitis to Lead to Increased Demand
According to the Australian Institute of Health and Welfare, in 2014, around 4.5 million people suffered from allergic rhinitis in Australia. Certain indications of allergic rhinitis such as fever, cold and bad breath can be overcome using nasal sprays. A high prevalence of nasal disorders and allergies is likely to cause an increased adoption of nasal sprays, globally. The increased adoption may have a positive impact on the global market and are likely to favor growth of the market in the coming years.
As per a study by the Food and Drug Administration (FDA), in 2018, around 7.4 million adults in the U.S suffer from treatment-resistant depression. Increasing prevalence of this disorder may lead to increased chances of suicidal tendencies and hospitalization. Increasing hospitalization may lead to further demand for nasal sprays and thereby, enable growth of the global nasal sprays market in the forthcoming years.
Painless drug delivery modes are a major factor that may favor the growth of the global nasal sprays market. Additionally, ease of availability and improved patient convenience are other factors that may boost the market in coming years. Having said that, certain adverse reactions of nasal spray and side effects such as nasal dryness, congestion and inflammation may hamper the growth of the global nasal sprays market in the coming years.
Sample PDF Brochure:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
View Related Reports: